Found 300 results for development-awards-2

Gambling Industry Employee Recognition Award

(20AKL053)
2 Images

Custom Commemorative for Drug Licensing Agreement

Custom crystal commemorative, incorporating a periodic table theme, marking a licensing and commercialization agreement for a cancer drug developed by Rockville, Maryland-based biotech firm GlycoMimetics. The agreement applies to mainland China, Hong Kong, Taiwan, and Macau.

(20ALJ071)
1 Image

Flag-Themed Pharmaceutical Deal Toy

Custom crystal deal toy commemorating the acquisition of Canada’s Dalton Pharma Services by Japanese pharmaceutical firm Seikagaku Corporation.

(20AMF085)
2 Images
Crystal deal toy marking a cross-border acquisition of Canadian Dalton Pharma Services. The acquirer was Seikagaku Corporation, an R&D-centered Japanese pharmaceutical firm.

Team Acquisition and Integration Award

Crystal team award recognizing employees involved in the acquisition and integration of Órgano Sintesis. The Mexican chemical company was acquired by Cincinnati-based Pilot Chemical.

(20ACJ058)
1 Image

The “Classic” Deal Toy Connecting Harvard with “George of The Jungle”

August 9, 2023 by David Parry

The classic deal toy above may conjure up some dim memories, and not just of Casper the Friendly...

 Blog Post

Honoring the Guy Who Attacked You with a Four Iron

October 28, 2020 by David Parry

Over the years we've designed deal toys and custom awards in many media, including crystal, resin,...

 Blog Post

Mattress-Themed Earnings Commemorative

Crystal commemorative celebrating the achievement of an EBITDA target by Tempur Sealy International, the mattress manufacturer and marketer.

(20AKL365)
2 Images
Custom crystal celebrating the achievement of an earnings target by mattress company Tempur Sealy International.

ZoomInfo IPO Crystal Commemorative

Crystal commemorative celebrating the initial public offering of ZoomInfo Technologies. The Vancouver, Washington-based company provides databases for use by sales and marketing teams.

(20AKL269)
2 Images
Custom crystal marking the initial public offering of business-intelligence platform ZoomInfo Technologies. The company's shares trade on the Nasdaq.

New Drug Application Custom Crystal

Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma’s migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial.

(20ALJ356)
2 Images
Crystal commemorative marking the submission to the Food and Drug Administration (FDA) of a New Drug Application (NDA). INP104 was developed for the acute treatment of migraine headaches.